Ozempic and Wegovy maker Novo Nordisk quieted Wall Street's concerns with its fourth-quarter results and 2025 outlook.
Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales ...
EGOT winner Whoopi Goldberg railed against an ad that's circulating on social media with a manipulated version of her ...
While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...
Novo Nordisk’s multibillion-dollar honeymoon phase spearheaded by Ozempic and Wegovy is ending. Now the Danish drugmaker is ...
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
Investors are upset at a lack of clarity over the results of Wegovy successor CagriSema after trials published in December.
Online pharmacies will now have to employ stricter checks to stop people who are already a healthy weight or have a history ...